MARKET WIREYahoo Finance • 20h ago
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
Why PDEX Stock slipped -0.88% Today — RQD Quant Desk Flash
$57.65 -0.88% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $57.45
Pro-Dex Inc. (PDEX) carries a Roarable Rating of D+ (Sell) with 54/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $186.1M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on PDEX Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is PDEX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Pro-Dex Inc. (NASDAQ: PDEX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $57.65 (-0.88% 1D, market cap $186.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, PDEX ranks #221 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does PDEX compare to STIM and KTWO in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), PDEX carries a Roarable D+ (54/100 RQD), trailing P/E of 22.2x, gross margin of 29.3%, and ROIC of 23.2%. By comparison, STIM (Neuronetics Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $171.4M) and KTWO (K2 Capital Acquisition Corporation Class A Ordinary Share) posts a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $202.2M). Among the 5-stock peer group, PDEX leads on earnings multiple (22.2x) while UTMD leads on capital efficiency (26.9% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for PDEX?
▼
Per PDEX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000788920), Pro-Dex Inc. generated $66.6M in revenue (+23.7% YoY), $9.0M in net income, and -$2.9M in free cash flow against $62.3M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $57.45 (-0.35%)🧬 Disciplined Float (+0.52% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 54/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.7% avg 90D alpha vs SPY • 51.0% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk C+
Each axis scored 0–20
12M PRICE TARGET CONE-1.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PDEX)Realized 20D OHLCV Swing Band: ±9.4%
Deterministic 5-Pillar Attribution (54/100 Composite)
🔍 WHY PDEX SCORES 54/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (30% of score)
Altman Z-Score 9.08 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9
▲ #2 Bullish Driver: Cash Engine Quality+11/20 pts (20% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 29.3% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning6/20 pts (-14 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$62.27-4.6% Next Q
62
Q2 (-2Q)Grade C$59.40+4.8% Next Q
59
Q3 (-1Q)Grade C$62.27-7.4% Next Q
57
CurrentGrade D+$57.65-0.7% Hist 90D α
54
Trajectory: C+ (62) → D+ (54)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a PDEX Turnaround Squeeze
While PDEX currently carries a cautious 54/100 (D+) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Clean SEC annual filing review with no major hidden accounting time-bombs.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($64.51) and Max Pain ($60.53) forces dealer call-delta covering toward $80.85.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.52% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PDEX• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PDEX Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PDEX Stock slipped -0.88% Today — RQD Quant Desk Flash
Pro-Dex Inc. (PDEX) slipped -0.88% to $57.65, trading at 60% of its 52-week range ($28.81 – $77). Stretched risk/reward at 22x P/E (23% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 60% of its 52-week range ($28.81 – $77) with RSI-14 at 41.1 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.4% around $57.65 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 29.3% gross margin and $0 annual free cash flow.
Live PDEX Headlines & Catalysts
MARKET WIRETradingView • 23h ago
Pro-Dex, Inc. Estimates – NASDAQ:PDEXTradingView report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGuruFocus • 1d ago
Pro-Dex Inc (PDEX) Reports Q1 FY2027 Earnings: Revenue Hits $20.GuruFocus report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
Gross margin rose to 33% at Pro-Dex (PDEX), but net income went the other way.Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 1d ago
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?TradingView report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
Sales rise 11% at Pro-Dex (PDEX), but earnings move the other way.Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.dars.gov.et/ • 1d ago
Pro-Dex Inc. (PDEX) Slips 2.93% to $58.26 as Shares Test Lower End of Recent Range - MESA MAhttps://www.dars.gov.et/ report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
Pro-Dex (PDEX) unit signs a new industrial lease starting at $11,600 a month.Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
CATALYSTChartMill • 4d ago
Pro-Dex (NASDAQ:PDEX) EPS Beat and Margin Expansion Offset In-Line RevenuePro-Dex Q1 EPS beat consensus by 35% while revenue met estimates; gross margin rose to 33% on favorable product mix, lifting shares after hours.
MARKET WIREYahoo • 4d ago
Pro-Dex, Inc. Announces Fiscal 2027 First Quarter ResultsIRVINE, CA / ACCESS Newswire / October 29, 2026 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2027 first quarter ended September 30, 2026.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PDEX)
- ✓Walkthrough of PDEX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PDEX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +12.53%🛡️ HOLDING TREND SUPPORT
2026-11-03O $61.60H $61.60L $57.65C $57.65VOL 38.5K
RES: $81.98SUP: $56.53SMA50: $64.51SMA200: $56.74
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PDEX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
15.9%/yr Implied 5Y Growth
vs. +23.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on PDEX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PDEX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PDEX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PDEX)
Health Care Rank #221 of 1016
⚔️ STIM vs PDEX Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PDEX vs. STIM, KTWO, UTMD, PROF)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Pro-Dex Inc. (PDEX) ranks #221 by composite RQD confidence (54/100, grade D+) and #583 by equity capitalization ($186.1M). Within this direct 5-issuer industry benchmark cohort, PDEX leads on earnings valuation at 22.2x trailing P/E, while UTMD leads on capital efficiency and profitability with 26.9% ROIC and 57.1% gross margin. UTMD currently holds the highest overall quantitative score in the immediate peer group at 62/100 (C) compared with PDEX at 54/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PDEX
ACTIVE
Pro-Dex Inc. | D+ | 54/100 | 22.2x | 29.3% | 23.2% | -0.88% | $186.1M | Benchmark Subject |
| STIM Neuronetics Inc. | E | 28/100 | — | 48.5% | -35.0% | -8.44% | $171.4M | /stim-vs-pdex → |
| KTWO K2 Capital Acquisition Corporation Class A Ordinary Share | D+ | 56/100 | — | — | — | +0.20% | $202.2M | /ktwo-vs-pdex → |
| UTMD Utah Medical Products Inc. | C | 62/100 | — | 57.1% | 26.9% | +3.64% | $216.7M | /utmd-vs-pdex → |
| PROF Profound Medical Corp. | D- | 40/100 | — | 70.8% | -35.0% | +2.44% | $240.0M | /prof-vs-pdex → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0000788920In its most recent audited fiscal period (FY2025, filed 2025-06-30), Pro-Dex Inc. (PDEX) reported GAAP revenue of $66.6M (+23.7% vs. FY2024 revenue of $53.8M , and +44.5% cumulative change since FY2023) , GAAP net income of $9.0M, operating cash flow of -$1.7M, and free cash flow of -$2.9M (-147.0% YoY). On the balance sheet, PDEX closed FY2025 with $62.3M in total assets against $0 in total debt (Altman Z-Score: 9.08, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $66.6M | $9.0M | -$1.7M | -$2.9M | $62.3M | — |
| FY2024 (FY) | 2024-06-30 | $53.8M | $2.1M | $6.2M | $6.2M | $60.4M | — |
| FY2023 (FY) | 2023-06-30 | $46.1M | $7.1M | $5.5M | $5.5M | — | — |
3. PDEX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PDEX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Pro-Dex Inc. (NASDAQ: PDEX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $57.65 (-0.88% 1D, market cap $186.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, PDEX ranks #221 in composite RQD confidence.
How does PDEX compare to STIM and KTWO in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), PDEX carries a Roarable D+ (54/100 RQD), trailing P/E of 22.2x, gross margin of 29.3%, and ROIC of 23.2%. By comparison, STIM (Neuronetics Inc.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $171.4M) and KTWO (K2 Capital Acquisition Corporation Class A Ordinary Share) posts a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $202.2M). Among the 5-stock peer group, PDEX leads on earnings multiple (22.2x) while UTMD leads on capital efficiency (26.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PDEX?
Per PDEX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000788920), Pro-Dex Inc. generated $66.6M in revenue (+23.7% YoY), $9.0M in net income, and -$2.9M in free cash flow against $62.3M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PDEX trading relative to its 50-day, 200-day, and 52-week technical levels?
PDEX last traded at $57.65 (-0.88% on volume of 63,158 shares), positioning the stock -10.63% below its 50-day simple moving average ($64.51) and +1.60% above its 200-day simple moving average ($56.74). Across its 52-week range of $28.81 to $77.00, PDEX sits at the 59.8% percentile with a 14-day RSI of 41.1 (NEUTRAL RANGE) and an implied next-earnings move of ±9.4% ($52.23 to $63.07).
ROARABLE RATING BRIEF • RQD 54/100 (D+)
✓ STAGE-C NUMBER FIREWALL VERIFIED
PDEX — Pro-Dex Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:41:17Z
1. Roarable Rating Brief: What This Means to a Prospective Investor
PDEX scores 58 out of 100, grading D+ and carrying the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 11 / 20 (ROIC 23.2%; FCF yield -1.47%), Whale 13F Flow at 9 / 20 (institutional accumulation and options positioning), Insider Conviction at 10 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 12 / 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 16 / 20 (Altman Z 9.08; Piotroski F 5/9; Debt/Equity 0.5).
For a prospective investor, the profile is mixed. The strongest pillar is the forensic balance sheet, which the rating treats as the most supportive element. The weakest pillars are whale flow and insider conviction, which the rating scores as the least supportive, and the cash engine, where a negative FCF yield offsets a high ROIC. The rating's verdict reflects the aggregate of these pillars rather than any single factor. Valuation context per the market data is a trailing P/E of 22.2 against a forward P/E of 18.
2. Business Model, Unit Margins & SEC Financial Trajectory
Pro-Dex Inc. (PDEX) is a NASDAQ-listed issuer in the Health Care sector, operating in the Medical/Dental Instruments industry. The profile describes the company as having a market capitalization of $0.2B. Specific product lines, customer base, and revenue model details are —
Per the market data, gross margin is 29.3%, operating margin 16.1%, and net margin 13.5%, with ROIC at 23.2% and FCF yield at -1.47%. The Altman Z-Score is 9.08, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. FY 2025 free cash flow was negative at -$2.9M, a reversal from positive FCF in the prior two reported periods. Full debt and EPS figures for the reported periods are —
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case: Forensic balance sheet scores 16 of 20 with Altman Z 9.08 and Debt/Equity 0.5, and FY 2025 operating income of $10.7M sits above net income of $9.0M. With Fundamental Cash Engine at 11/20 (ROIC 23.2%, FCF yield -1.47%) and Institutional Whale Flow at 6/20, sustained execution supports upside toward the top of the $28.81 – $77.00 52-week range.
- 🐻 Primary Bear Case: FY 2025 free cash flow turned negative at -$2.9M and FCF yield is -1.47%, with whale and insider pillars scoring 9 and 10 of 20. Investors must weigh 22.2x trailing P/E and 16.5x EV/EBITDA against 16.1% operating margins and a 1.00 macro beta if sector demand softens.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies, sector correlations, and second-order bottlenecks are —
- Key Question #1: What drove the FY 2025 swing from positive FCF in prior periods to -$2.9M, and does it persist?
- Key Question #2: Why do the FY 2025 operating income ($10.7M) and net income ($9.0M) figures diverge from the trend the news headlines describe?
- Key Question #3: What are the debt levels and EPS for each reported period, given that those fields are N/A or missing?
PDEX Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Pro-Dex Inc. (PDEX) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 20h ago
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates Yahoo Finance report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 23h ago
Pro-Dex, Inc. Estimates – NASDAQ:PDEX TradingView report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GuruFocus • 1d ago
Pro-Dex Inc (PDEX) Reports Q1 FY2027 Earnings: Revenue Hits $20. GuruFocus report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
Gross margin rose to 33% at Pro-Dex (PDEX), but net income went the other way. Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 1d ago
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth? TradingView report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
Sales rise 11% at Pro-Dex (PDEX), but earnings move the other way. Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago
Pro-Dex Inc. (PDEX) Slips 2.93% to $58.26 as Shares Test Lower End of Recent Range - MESA MA https://www.dars.gov.et/ report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
Pro-Dex (PDEX) unit signs a new industrial lease starting at $11,600 a month. Stock Titan report covering Pro-Dex Inc. (PDEX) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
PDEX Bull vs. Bear Conversation Board — What's Your Call at $57.65?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PDEX 🐻 33% BEARISH CONVICTION
CA CashFlowKing FCF Compounder Hunter 🐂 BULLISH
🎯 Target: $72.12 (+24.0%)
📌 Pinned Debate Forensic balance sheet scores 16 of 20 with Altman Z 9.08 and Debt/Equity 0.5, and FY 2025 operating income of $10.7M sits above net in
Here is why I am bullish on PDEX here at $58.16: Forensic balance sheet scores 16 of 20 with Altman Z 9.08 and Debt/Equity 0.5, and FY 2025 operating income of $10.7M sits above net income of $9.0M.. Compare PDEX's 16.1% operating margin and 23.2% ROIC against the rest of Medical/Dental Instruments. As long as cash conversion holds up, dips toward $55.25 are getting bought.
SectorRotator 🐂 BULL
@CashFlowKing Agree on the RQD 54/100 quality, though with 1.0 beta I'm scaling in with half-size at $58.16 and keeping dry powder in case we test $54.09.
FA FadeTheHype Contrarian Tape Reader 🐻 BEARISH
🎯 Target: $45.95 (-21.0%)
Spot @ $58.16 FY 2025 free cash flow turned negative at -$2.9M and FCF yield is -1.47%, with whale and insider pillars scoring 9 and 10 of 20.
FY 2025 free cash flow turned negative at -$2.9M and FCF yield is -1.47%, with whale and insider pillars scoring 9 and 10 of 20.. Look at the math on PDEX: paying 22.2x trailing P/E for 23.2% ROIC and 16.1% operating margins leaves zero margin of safety if Medical/Dental Instruments demand softens. I'd wait for a retest of $51.18 before getting long.